retatrutide phase 2 obesity trial results The Effect of on Kidney Parameters in Participants With Type Diabetes Mellitus and/or Advancements in Clinical Research and

Mechanisms identified include: increased cardiac utilization of ketones increased autophagy (recycling of intracellular components)l decreased inflammation & oxidative stress improved mitochondrial function decreased intracellular Ca & Na overload decreased fibrosis improved myocardial diastolic function decrease myocardial hypertrophy Indications: Type 2 diabetes Adjunct therapy in patients not meeting their glycemic goal with other agents (e.g

GLP-1 Medications GLP-1 (Glucagon-like peptide-1) medications are a type of injectable medication used for the treatment of obesity

Adv Nutr

Researchers suggested that the anti-inflammatory effects of GLP-2 are IL-10-independent and that GLP-2 alters the mucosal response to inflammation through a decrease of lamina propria macrophage TNF- as well as an increase in insulin-like growth factor 1 (IGF-1) production (Ivory et al

The federal government said last year that it could cost about $25b for Medicare and $11b for Medicaid to provide the drugs over the next 10 years